New Study

The new study in JAMA Oncology by Molinaro et al (see useful links) suggest a benefit of adding a margin. Although promising the findings are limited of the usual limitation of case selection in retrospective series. We think this emphasize the need to perform a clinical trial. The supramarginal trial.

Previous
Previous

Approvals

Next
Next

Funding agencies